MHRA Trusted Advisory Group (TAG) Update and Next Steps

Introduction: MHRA Trusted Advisory Group (TAG)

The TAG has been established to work in unison to tackle a number of common challenges that may impact and improve the availability of radiopharmaceuticals within the UK. By working in collaboration with the community, the TAG aims to achieve its overarching goal:

To elevate and improve radiopharmaceutical-based services in the UK by working together to provide supply security, maintain patient safety and foster innovation and growth in the sector.

The TAG unites key stakeholders across the community, including representatives from academia, the NHS and commercial radiopharmacy teams, clinicians, the National PET Imaging Platform, and the MHRA.

It is governed by principles that allow meaningful exchange of views. By facilitating open and honest dialogue, proposing new, more effective ways of working, incorporating best practices, and resolving common problems, the TAG’s outputs aim to improve the robust supply of radiopharmaceuticals in the UK and ensure patient safety and product quality.

The current priorities of the TAG are:

• Supporting radiopharmacies in maintaining compliance
• Production of guidance materials for radiopharmacy best practice
• Production of a strategic road map
• Liaising with the MHRA and the community to provide feedback on guidelines and regulations.

Read the full poster presented at the BNMS Autumn Meeting:

Posted 30 / 09 / 25